LANTHEUS HOLDINGS INC (LNTH)
Sector: Health Care
| Ticker | Position | Age | Qualifications and Experience | Committee Memberships | Filing Year |
|---|---|---|---|---|---|
Sector: Health Care
| Ticker | Position | Age | Qualifications and Experience | Committee Memberships | Filing Year |
|---|---|---|---|---|---|
Director information for LNTH
| Ticker | Position | Age | Qualifications and Experience | Committee Memberships | Filing Year |
|---|---|---|---|---|---|
| LNTH | Member; Director | 52 | ["Current Head of Oncology Therapeutic Area Unit (OTAU) at Takeda", "Former Chief Medical Officer, CRISPR Therapeutics", "Former Vice President and Global Therapeutic Area Head of Hematology, GI Oncology, GU Oncology, and Bone Diseases, Amgen", "Former Assistant Professor in the Department of Breast Medical Oncology at the University of Texas MD Anderson Cancer Center", "Hematology/Oncology fellowship at the University of Texas MD Anderson Cancer Center", "Clifton D. Howe (Fellow of the Year) Award", "American Society of Clinical Oncology Young Investigator Award", "Lyndon Baines Johnson Chief Fellow", "Internal medicine residency at Baylor College of Medicine", "M.D., University of Texas Medical School at Houston"] | ["Member", "Science and Technology Committee", "Science andTechnologyCommittee", "Talent andCompensationCommittee"] | 2026 |